AF
CRDF icon

Allworth Financial’s Cardiff Oncology CRDF Stock Holding History

Allworth Financial’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$33 Buy
+20
New +$41 ﹤0.01% 5103
2025
Q3 		– Sell
-100
Closed -$315 – 4937
2025
Q2 		$315 Hold
100
– – ﹤0.01% 4238
2025
Q1 		$290 Hold
100
– – ﹤0.01% 3802
2024
Q4 		$354 Hold
100
– – ﹤0.01% 3677
2024
Q3 		$267 Hold
100
– – ﹤0.01% 3545
2024
Q2 		$225 Hold
100
– – ﹤0.01% 3535
2024
Q1 		$534 Hold
100
– – ﹤0.01% 3268
2023
Q4 		$148 Hold
100
– – ﹤0.01% 3316
2023
Q3 		$139 Hold
100
– – ﹤0.01% 3279
2023
Q2 		$147 Hold
100
– – ﹤0.01% 3141
2023
Q1 		$165 Hold
100
– – ﹤0.01% 3045
2022
Q4 		$140 Hold
100
– – ﹤0.01% 2874
2022
Q3 		$0 Hold
100
– – ﹤0.01% 2729
2022
Q2 		$0 Hold
100
– – ﹤0.01% 2463
2022
Q1 		$0 Hold
100
– – ﹤0.01% 2157
2021
Q4 		$1K Hold
100
– – ﹤0.01% 1802
2021
Q3 		$1K Hold
100
– – ﹤0.01% 1738
2021
Q2 		$1K Sell
100
-858
-90% -$7.28K ﹤0.01% 1449
2021
Q1 		$9K Buy
+958
New +$11.6K ﹤0.01% 1009

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Allworth Financial's CRDF Position: Q1 2026 in Review

Allworth Financial opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 20 shares worth $33. The stake represents ﹤0.01% of the portfolio and ranks #5103 among its holdings. This is a return to the name: Allworth Financial previously reported a position in CRDF as recently as Q2 2025.

Allworth Financial first reported a position in CRDF in Q1 2021 and has held it in 19 quarters since. The position peaked at $9K in Q1 2021. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Allworth Financial held 20 shares of Cardiff Oncology worth $33 as of Q1 2026.
  • Cardiff Oncology was a new Allworth Financial position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Allworth Financial's portfolio in Q1 2026, its #5103 holding.
  • Allworth Financial first reported a position in Cardiff Oncology in Q1 2021 and has held it in 19 quarters since.
  • Allworth Financial's Cardiff Oncology position peaked at $9K in Q1 2021.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Allworth Financial's 13F filing for Q1 2026, filed 15 May 2026.